Preparation of slightly hydrophobic heparin derivatives which can be used for solvent casting in polymeric formulation

Thrombosis Research

Volumn 92, Issue 4, 1998, Pages 149-156

  Lee, Yong kyu ^a   Moon, Hyun Tae ^a   Byun, Youngro ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Alkanoic acid; Cholesterol; Deoxycholic acid; Hydrophobic heparin; Solvent casting

Indexed keywords

ACETONE; CHOLESTEROL; DEOXYCHOLIC ACID; DICYCLOHEXYLCARBODIIMIDE; DRUG SOLVENT; HEPARIN DERIVATIVE; LAURIC ACID; N,N DIMETHYLFORMAMIDE; PALMITIC ACID; POLYMER; SUCCINIMIDE DERIVATIVE; WATER;

ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL KIDNEY; CARDIOPULMONARY BYPASS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; HYDROPHILICITY; HYDROPHOBICITY; INTRAVENOUS DRUG ADMINISTRATION; OXYGENATOR; PRIORITY JOURNAL;

CHOLESTEROL; CHROMATOGRAPHY; DEOXYCHOLIC ACID; DRUG DELIVERY SYSTEMS; HEPARIN; LAURIC ACIDS; PALMITIC ACID; POLYMERS; SOLUBILITY; SPECTRUM ANALYSIS;

EID: 0032533809     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00124-8     Document Type: Article

References (19)

1. Damus P.S., Hicks M., Rosenberg R.B. Anticoagulant action of heparin. Nature. 246:1977;355.
2. Casu B. Structure and biological activity of heparin. Adv Carbohydr Chem Biochem. 43:1985;51-134.
3. Mcavoy T.J. The biologic half-life of heparin. Clin Pharmacol Ther. 25:1979;372-379.
4. Perry P.J., Herron G.R., King J.C. Heparin half-life in normal and impaired renal function. Clin Pharmacol Ther. 16:1974;514-519.
5. Ranade V.V. Drug delivery systems 5A. Oral drug delivery. J Clin Pharmacol. 31:1991;2-16.
6. Gott V.L., Shiffen J.D., Dutton R.S. Heparin bonding on colloidal graphite surfaces. Science. 142:1985;1297-1298.
7. Leininger L., Cooper C.W., Falb R.D., Grode G.A. Nonthrombogenic plastic surfaces. Science. 152:1966;1625-1626.
8. Grode G.A., Falb R.D., Crowly C. Biocompatible materials for use in the vascular system. J Biomed Mater Res Symp. 3:1972;77-84.
9. Eloy R., Belleville J., Paul J., Pusinéri C., Baguet J., Rissoan M.-C., Cathignol D., Ffrench P., Ville D., Tartullier M. Thromboresistance of bulk heparinized catheters in human. Thromb Res. 45:1987;223-233.
10. Tanzawa H., Mori Y., Harumiya N., Miyama H., Hori M., Oshima N., Idezuki Y. Preparation and evaluation of a new antithrombo genic heparinized hydrophilic polymer for use in cardiovascular system. ASAIO J. 14:1973;188-194.
11. Hufnagel C.A., Conrad P.W., Gillespie J.F., Pifarre R., Ilano A., Yokoyama T. Characteristics of materials for intravascular applications. Ann NY Acad Sci. 146:1968;262-270.
12. Holland E.F., Gidden H.E., Mason R.G., Klein E. Thrombogenicity of heparin-bound DEAE cellulose hemodialysis membranes. ASAIO J. 1:1978;24-36.
13. Jacobs H., Okano T., Lin J., Kim S.W. PEG1-heparin conjugate releasing polymers. J Control Rel. 2:1985;313-319.
14. Okor R.S., Anderson W. Casting solvent effects on the permeability of polymer films of differing quaternary ammonium(cation) content. J Pharmacol. 39:1987;547-548.
15. Barzu T., Desmouliere A., Herbert J.M., Level M., Herault J.P., Petitou M., Lormeau J.-C., Gabbiani G., Pascal M. O-acylated heparin derivatives with low anticoagulant activity decrease proliferation and increase alpha-smooth muscle actin expression in cultured arterial smooth muscle cells. Eur J Pharmacol. 219:1992;225-233.
16. Liu I., Pervin A., Gallo C.M., Desai U.R., van Gorp C.L., Linhardt R.J. New approaches for the preparation of hydrophobic heparin derivatives. J Pham Sci. 83:1994;1034-1039.
17. Nagasawa K., Uchiyama H., Yajima D. Anticoagulant effect of low molecular weight fractions derived from a chemically modified heparin. Thromb Res. 64:1991;521-525.
18. Linhardt R.J. Carbohydrates. Ogura H., Hasegawa A., Suami T. Carbohydrates. Synthetic Methods and Applications in Medicinal Chemistry:1992;387-403 Kodansha/VCH Publishers, Tokyo.
19. Ebert C.D., Kim S.W. Immobilized heparin. spacer arm effects on biological interactions Thromb Res. 26:1982;43-57.